Susan Foden
Non-executive director
pharmaceutical
BTG plc
China
Biography
Dr. Susan Foden, MA, DPhil was appointed to the Board March 2015. She is a member of the Remuneration Committee. Other directorships: Susan currently holds non-executive roles with BerGenBio ASA, Evgen Pharma plc and Vectura Group plc, and is an advisory board member for CD3 (a joint initiative between Leuven University and the European Investment Fund). Expertise and experience: Susan brings extensive industry experience to the BTG Board with a strong track record of having assisted in the development of a number of businesses in the sector. She was Investor Director with the venture capital firm Merlin Biosciences, was formerly CEO of the technology transfer company, Cancer Research Campaign Technology Ltd and was Head of Academic Liaison at Celltech Ltd.
Research Interest
pharmaceutical
